PAZOPANIB Efficacy and Tolerance in Desmoids Tumors
NCT01876082
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Progressive Desmoids Tumors
Interventions
DRUG:
PAZOPANIB treatment
DRUG:
Active Comparator: Vinblastine and Methotrexate
Sponsor
Institut Bergonié